PIK3CA and cancer: Treatment with BYL719 appeared to reduce cell numbers and viability less than pan PI3K inhibition (Figure 2a,b); therefore, we next investigated whether p110β could have any compensatory role upon p110α inhibition, as observed in some cancer settings [36,37].